BetterLife Subsidiary, Altum Pharmaceuticals, to Conduct Randomized Placebo-controlled COVID-19 Trial Using AP-003

by NASDAQ Market News March 11, 2021

NASDAQ Market News
Click here to email author

Aeterna Zentaris Continues to Demonstrate Pipeline Expansion – Announces the Initiation of Its Preclinical Program for the Potential Treatment of Primary Hypoparathyroidism

Acerus Reports Fourth Quarter and Full Year 2020 Financial Results

Ads